Suzanne Nowicki
About Suzanne Nowicki
Suzanne Nowicki is an Oncology Account Manager at Mirati Therapeutics, where she has worked since 2022. She has extensive experience in oncology sales, having held positions at Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline.
Work at Mirati Therapeutics
Suzanne Nowicki currently serves as an Oncology Account Manager at Mirati Therapeutics, a position she has held since 2022. She operates remotely from Chicago, Illinois. In her role, she focuses on managing oncology accounts and building relationships within the oncology sector. Following the acquisition of Mirati Therapeutics by Bristol Myers Squibb in January 2024, she continued in her position, contributing to the integration of the two organizations.
Previous Experience at Boehringer Ingelheim
Before joining Mirati Therapeutics, Suzanne Nowicki worked at Boehringer Ingelheim as an Oncology Key Account Sales Manager and Certified Field Trainer from 2015 to 2016. In this role, she was responsible for managing key oncology accounts and training field sales representatives, enhancing their capabilities in oncology product sales.
Experience at AstraZeneca
Suzanne Nowicki was employed at AstraZeneca from 2016 to 2022 as a Clinical Oncology Specialist and Field Sales Trainer. Over the course of six years, she developed expertise in clinical oncology and played a key role in training sales teams, ensuring they were well-equipped to address the needs of healthcare providers in the oncology field.
Background in Pharmaceutical Sales
Suzanne Nowicki began her career in pharmaceutical sales at GlaxoSmithKline, where she worked as a Senior Executive Pharmaceutical Sales Representative from 2000 to 2009. This nine-year tenure provided her with foundational experience in sales and account management within the pharmaceutical industry, preparing her for subsequent roles in oncology sales.
Education and Expertise
Suzanne Nowicki studied at Western Illinois University, where she gained knowledge that supports her career in oncology sales. Her educational background, combined with extensive experience in pharmaceutical sales, has equipped her with the skills necessary to excel in her current role and contribute to advancements in oncology treatment.